CNS Pharmaceuticals, Inc. Common Stock Shares Outstanding

Quick Answer

CNS Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 632,516 shares for the year ending 2025.

  • CNS Pharmaceuticals, Inc. showed an increase of +437.0% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from CNS Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), CNS Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has declined by 95.0%.
  • Historical annual values: Fiscal year 2025: 632,516 shares | Fiscal year 2024: 117,796 shares | Fiscal year 2023: 2,486 shares | Fiscal year 2022: 1.62 million shares | Fiscal year 2021: 949,052 shares | Fiscal year 2020: 23.86 million shares | Fiscal year 2019: 16.45 million shares | Fiscal year 2018: 12.69 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: